Invitation to Submit Proposals under Framework Agreements 2022/0019 - Antipsychotic, Anesthetic, and Muscle Relaxant Medications; 2023/0436 - Central Nervous System Medications; 2023/0437 - Anti-allergic Medication, Vitamins, and Mineral Salts, and Medications Used in the Treatment of Intoxications; 2023/0491 - Oncological and Immunomodulatory Medications; 2024/1077 - Miscellaneous Medications (II).

This tender is an invitation for proposals under several established framework agreements. The purpose is to procure a wide range of pharmaceutical products essential for various medical treatments. Specifically, the framework agreements cover: antipsychotic, anesthetic, and muscle relaxant medications (2022/0019); medications for the central nervous system (2023/0436); anti-allergic medications, vitamins, mineral salts, and treatments for intoxication (2023/0437); oncological and immunomodulatory drugs (2023/0491); and miscellaneous medications (II) (2024/1077). Healthcare providers or authorized entities are invited to submit proposals to supply these medications. The objective is to ensure a consistent and reliable supply of these critical drugs, meeting the diverse therapeutic needs of patients. By leveraging existing framework agreements, the procurement process aims for efficiency, competitive pricing, and adherence to quality standards for pharmaceutical products.

This is a supplies contract in the health and medical services, mining and extractives and information and communication technology sectors, with a focus on Pharmaceuticals. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 263,812.

Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.